Skip to main content
Log in

Antioxidant probucol as an effective scavenger of lipid radicals in low density lipoproteinsin vivo andin vitro

  • Biophysics and Biochemistry
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Probucol in concentrations of 10–15 μM effectively inhibits Cu2+-induced free radical oxidation of native low density lipoproteins and in concentration of 100 μM it inhibits lipoperoxide formation. The mean plasma concentration of probucol in patients receiving 250 mg of this drug is 25 μM. Both 250 and 1000 mg probucol daily during 3–6 month block the oxidation of isolated low density lipoproteins. Electron paramagnetic resonance spectrometry data showed that probucol incorporatedin vivo into lipoprotein particles interacts with lipid radicals yielding long-lived phenoxyradicals. Probucol can be used in complex therapy of atherosclerosis as an antioxidant drug and its dose required for lipoprotein protection against atherogenic modification can be decreased to 250 mg/day.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. T. M. Zaitseva, V. N. Lupanov, A. A. Lyakishev, and V. N. Titov,Farmatsiya, No. 3, 12–15 (1994).

    Google Scholar 

  2. V. Z. Lankin, A. M. Vikhert, A. K. Tikhaze,et al., Vopr. Med. Khimii, No. 3, 18–24 (1989).

    Google Scholar 

  3. V. Z. Lankin, V. P. Lupanov, A. A. Lyakishev, and V. M. Revenko,Kardiologiya,31, No. 6, 87–90 (1991).

    PubMed  CAS  Google Scholar 

  4. V. Z. Lankin, V. A. Roginskii, A. K. Tikhaze,et al., Dokl. Ross. Acad. Nauk,351, No. 4, 554–557 (1996).

    CAS  Google Scholar 

  5. A. K. Tikhaze, V. Z. Lankin, S. V. Kolycheva,et al., Byull. Eksp. Biol. Med.,126, No. 11, 551–554 (1998).

    CAS  Google Scholar 

  6. K. B. Shumaev, E. K. Ruuge, A. A. Dmitrovskii,et al., Biokhimiya,62, No. 6, 769–773 (1997).

    Google Scholar 

  7. L. S. Cristol, I. Jialal, and S. M. Grundy,Atherosclerosis,97, 11–20 (1992).

    Article  PubMed  CAS  Google Scholar 

  8. C. A. Dujovne, W. S. Harris, and L. L. C. Gerrond,Am. J. Cardiol.,74, 38–42 (1994).

    Article  PubMed  CAS  Google Scholar 

  9. M. Kuzuya and F. Kuzuya,Free Radic. Biol. Med.,14, 67–77 (1993).

    Article  PubMed  CAS  Google Scholar 

  10. V. Lankin, H. Kuhn, C. Hiebsch,et al., Biomed. Biochem. Acta,44, 655–664 (1985).

    CAS  Google Scholar 

  11. S. J. T. Mao, M. T. Y. Yates, R. A. Parker,et al., J. Arterioscler. Thromb.,11, 1266–1275 (1991).

    CAS  Google Scholar 

  12. J. Nourooz-Zadeh, J. Tajaddini-Sarmadi, and S. R. Wolff,Anal. Biochem.,220, 403–409 (1994).

    Article  PubMed  CAS  Google Scholar 

  13. J. Rodes, G. Cote, J. Lesperance,et al., Circulation,97, 429–436 (1998).

    PubMed  CAS  Google Scholar 

  14. V. V. Tertov, V. V. Kaplun, S. N. Dvoryantsev, and A. N. Orekhov,Biochem. Biophys. Res. Commun.,214, No. 2, 608–613 (1995).

    Article  PubMed  CAS  Google Scholar 

  15. H. Yokoi, H. Daida, Y. Kuwabara,et al., J. Am. Coll. Cardiol.,30, 855–862 (1997).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 128, No. 8, pp. 186–189, August, 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tikhaze, A.K., Lankin, B.Z., Konovalova, G.G. et al. Antioxidant probucol as an effective scavenger of lipid radicals in low density lipoproteinsin vivo andin vitro . Bull Exp Biol Med 128, 818–821 (1999). https://doi.org/10.1007/BF02433824

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02433824

Key Words

Navigation